Cancer Research Institute and Chordoma Foundation Partner to Advance Immunotherapy Research in Rare Cancer
June 28, 2019
June 28, 2019
NEW YORK, June 28 -- Cancer Research Institute issued the following news:
NEW YORK and DURHAM, NC --The Cancer Research Institute (CRI) and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family that occurs in the bones of the skull base and spine. Through this partnership, the two organizations will identify and fund promising chordoma research based in the field of . . .
NEW YORK and DURHAM, NC --The Cancer Research Institute (CRI) and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family that occurs in the bones of the skull base and spine. Through this partnership, the two organizations will identify and fund promising chordoma research based in the field of . . .